Stay updated on Oral Gallium Maltolate for Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Oral Gallium Maltolate for Glioblastoma Clinical Trial page.

Latest updates to the Oral Gallium Maltolate for Glioblastoma Clinical Trial page
- Check7 days agoChange DetectedNo significant changes were detected on the Study Details page. Core sections such as title, conditions, eligibility criteria, design, and outcome measures appear unchanged.SummaryDifference0.5%

- Check14 days agoNo Change Detected
- Check36 days agoChange DetectedKey changes indicate a shift to current operating status and updated versioning (e.g., Active status, current date fields, and new revision v3.2.0), while removing older recruitment and contact details and earlier dates.SummaryDifference4%

- Check43 days agoChange DetectedUpdated revision to v3.1.0 and added new contact details (phone extension and email), replacing the previous v3.0.2 revision.SummaryDifference0.1%

- Check57 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2; the 'Back to Top' navigation element has been removed.SummaryDifference0.1%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

- Check72 days agoChange DetectedThe web page has updated its facility name and location details while removing specific location terms and drug information related to gallium. Additionally, the revision number has been updated from v2.16.12 to v3.0.0.SummaryDifference0.8%

Stay in the know with updates to Oral Gallium Maltolate for Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Gallium Maltolate for Glioblastoma Clinical Trial page.